CHLAMYDIA PNEUMONIAE IGA

CHLAMYDIA PNEUMONIAE IgA is a serological test that detects IgA-class antibodies directed against Chlamydia pneumoniae, a common cause of atypical respiratory infections. The test typically uses an ELISA or immunoassay on a serum sample collected by certified phlebotomists and processed in accredited Dubai, UAE laboratories to identify recent or ongoing respiratory infection.

This test is useful for patients with persistent cough, suspected atypical pneumonia, or worsening chronic respiratory conditions where Chlamydia pneumoniae is a consideration. Results support clinicians in deciding on appropriate antibiotic therapy or additional diagnostics; however, serology may be complemented by PCR or paired sera for definitive timing of infection and to avoid interpretation limitations such as cross-reactivity or early-window false negatives.

• Chlamydia pneumoniae IgA (serum)
• IgA Titre / Index
• Result Interpretation (Reactive / Non-reactive)

• Persistent dry or productive cough lasting more than 1–2 weeks
• Suspected atypical pneumonia or community-acquired pneumonia
• Acute exacerbation of chronic bronchitis or asthma
• Recent exposure in institutional or workplace respiratory outbreaks
• When PCR is unavailable or to assess immune response in subacute illness

• At‑home sample collection with discreet, certified Dubai lab processing
• Fast, confidential reporting to support timely treatment decisions
• Detects IgA response indicative of recent mucosal infection
• Reduces need for immediate clinic visit—suitable for homebound patients
• Results interpreted by accredited laboratory standards compliant with UAE regulations

• At‑home venous blood collection (serum sample) by trained phlebotomist
• No fasting required prior to sample collection
• Inform provider of recent antibiotics, immunosuppressants, or known immunodeficiency